Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Gori

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|April 12, 2026
Implementing SGLT2 Inhibitors in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Multidisciplinary Expert PerspectiveAngelo Avogaro, Mauro Gori, Giuseppe Grandaliano, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 20, 2018
Sacubitril/valsartan: from a large clinical trial to clinical practiceEdoardo Sciatti, Michele Senni, Carlo M Lombardi, et al.
Frontiers in Cardiovascular Medicine|April 23, 2025
A holistic approach to managing cardio-kidney metabolic syndrome: insights and recommendations from the Italian perspectiveMassimo Iacoviello, Mauro Gori, Giuseppe Grandaliano, et al.
European Heart Journal|August 18, 2005
End-systolic pressure/volume relationship during dobutamine stress echo: a prognostically useful non-invasive index of left ventricular contractilityAurelia Grosu, Tonino Bombardini, Michele Senni, et al.
Cardiac Failure Review|April 23, 2021
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient's Journey with Heart Failure and Reduced Ejection FractionMauro Gori, James L Januzzi, Emilia D'Elia, et al.
European Journal of Heart Failure|October 24, 2015
Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical useEmilia D'Elia, Muthiah Vaduganathan, Mauro Gori, et al.
Giornale Italiano Di Cardiologia (2006)|May 12, 2017
[The spiral of evil: iatrogenic coronary and aortic dissection]Paolo Canova, Giuseppe Musumeci, Roberta Rossini, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 2, 2019
Cardiac toxicity of combined vemurafenib and cobimetinib administration
Roberto Fiocchi, Mauro Gori, Filippo Taddei, et al.
International Journal of Cardiology|December 9, 2024
Serum uric acid, renal function and prognosis in patients with chronic heart failure and reduced ejection fraction. Insights from the Italian Network on Heart FailureCalogero Minneci, Mery Zucchini, Lucio Gonzini, et al.
Cardiac Failure Review|June 11, 2019
Treating Patients Following Hospitalisation for Acute Decompensated Heart Failure: An Insight into Reducing Early RehospitalisationsAttilio Iacovoni, Emilia D'Elia, Mauro Gori, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
European Heart Journal. Cardiovascular Pharmacotherapy|April 12, 2026
Implementing SGLT2 Inhibitors in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Multidisciplinary Expert PerspectiveAngelo Avogaro, Mauro Gori, Giuseppe Grandaliano, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 20, 2018
Sacubitril/valsartan: from a large clinical trial to clinical practiceEdoardo Sciatti, Michele Senni, Carlo M Lombardi, et al.
Frontiers in Cardiovascular Medicine|April 23, 2025
A holistic approach to managing cardio-kidney metabolic syndrome: insights and recommendations from the Italian perspectiveMassimo Iacoviello, Mauro Gori, Giuseppe Grandaliano, et al.
European Heart Journal|August 18, 2005
End-systolic pressure/volume relationship during dobutamine stress echo: a prognostically useful non-invasive index of left ventricular contractilityAurelia Grosu, Tonino Bombardini, Michele Senni, et al.
Cardiac Failure Review|April 23, 2021
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient's Journey with Heart Failure and Reduced Ejection FractionMauro Gori, James L Januzzi, Emilia D'Elia, et al.
European Journal of Heart Failure|October 24, 2015
Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical useEmilia D'Elia, Muthiah Vaduganathan, Mauro Gori, et al.
Giornale Italiano Di Cardiologia (2006)|May 12, 2017
[The spiral of evil: iatrogenic coronary and aortic dissection]Paolo Canova, Giuseppe Musumeci, Roberta Rossini, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 2, 2019
Cardiac toxicity of combined vemurafenib and cobimetinib administration
Roberto Fiocchi, Mauro Gori, Filippo Taddei, et al.
International Journal of Cardiology|December 9, 2024
Serum uric acid, renal function and prognosis in patients with chronic heart failure and reduced ejection fraction. Insights from the Italian Network on Heart FailureCalogero Minneci, Mery Zucchini, Lucio Gonzini, et al.
Cardiac Failure Review|June 11, 2019
Treating Patients Following Hospitalisation for Acute Decompensated Heart Failure: An Insight into Reducing Early RehospitalisationsAttilio Iacovoni, Emilia D'Elia, Mauro Gori, et al.
Pageof 11